Stifel analysts said that Lexeo’s data showing reduced size and thickness of the heart’s left ventricle are “supportive of a drug effect” for the company’s gene therapy in Friedreich’s ataxia ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. 24/7 Wall St. : Barry Bannister of Stifel forecasts a ...

A live webcast and replay of the fireside chat will be available on the Events & Presentations page in the Investor Relations section of Pyxis Oncology’s website, ir.pyxisoncology.com.

Martin Marietta Materials (NYSE:MLM – Free Report) had its price target lowered by Loop Capital from $645.00 to $615.00 in a report issued on Tuesday,Benzinga reports. The firm currently has a buy ...

Tenants include Partners Bank of California, Wells Fargo Advisors, Stifel, Nicolaus & Company ... market challenges for owners of office building,” said Will Dickinson, vice president at ...

While building cost inflation has moderated from ... there is still a long way to go.” Analysts at Stifel said a "dull" Spring Statement today from Rachel Reeves would be "cathartic" for ...

Stifel analyst Annabel Samimy initiated coverage of Palvella Therapeutics (PVLA) with a Buy rating and $45 price target Palvella, which ...

Welcome to Barron's Advisor! Our articles are free to Barron's subscribers and wealth management professionals. To subscribe to Barron's, click here. If you're a wealth managment professional and ...

A number of other research analysts have also recently issued reports on ABX. Stifel Nicolaus cut their price target on Barrick Gold from C$33.50 to C$32.00 in a report on Monday, December 2nd. TD ...